Terlipressin EVER Pharma - EVER Pharma Spain

Gastroenterology
2 Strengths – 1 mg/5 ml; 2 mg/10 ml

Terlipressin EVER Pharma is indicated for the treatment of bleeding oesophageal varices and Hepato-renal syndrome type 1.

NICE (UK) guidelines are to offer terlipressin to patients with suspected variceal bleeding at presentation and the WGO recommend it as the first choice for pharmacological therapy to control bleeding and mortality.

Learn more: www.evervalinject.com